Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intersect ENT Company Profile (NASDAQ:XENT)

Consensus Ratings for Intersect ENT (NASDAQ:XENT) (?)
Ratings Breakdown: 1 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.88)
Consensus Price Target: $26.30 (1.51% upside)

Analysts' Ratings History for Intersect ENT (NASDAQ:XENT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/21/2015Piper JaffrayBoost Price TargetOverweight$25.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
4/8/2015CRT CapitalInitiated CoverageBuy$32.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2015ZacksReiterated RatingHold -> Hold$29.10ViewTweet This Rating  Share This Rating on StockTwits
3/16/2015Canaccord GenuityInitiated CoverageBuy$27.00ViewTweet This Rating  Share This Rating on StockTwits
1/12/2015ZacksDowngradeOutperform -> Neutral$22.90ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015JPMorgan Chase & Co.Boost Price TargetOverweight$22.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
12/11/2014William BlairInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
10/21/2014ZacksUpgradeNeutral -> Outperform$17.60ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014WedbushInitiated CoverageOutperform$18.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014JPMorgan Chase & Co.Initiated CoverageOverweight$22.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Leerink SwannInitiated CoverageOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
8/18/2014Piper JaffrayInitiated CoverageOverweight$20.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/28/2013 forward)